This is supported by a proliferation decrease observed after the treatment with TGF-β1 in several B-ALL cell lines with different karyotypes, including the TEL-AML1+ REH ALL cell line. This evidence concerns the gene TGFB1 and precursor B-cell acute lymphoblastic leukemia.